Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Oxygenators, Heart-lung Machines), Ex Vivo Organ Perfusion, Technique (Normothermic, Hypothermic), Cell Perfusion, by Type (Microfluidic, Bioreactor)) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: April 2, 2020
Clear
SKU: GMS-1351 Category:

The market for perfusion systems is projected to reach USD 1,313 million by 2024, rising over the forecast period at a CAGR of 3.11%. The market for perfusion systems is driven by factors such as the increasing prevalence of cardiovascular and respiratory diseases, increased government and NGO donation programs, increased investment in cell-based research and increased activities in the manufacture of biological products.

Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Oxygenators, Heart-lung Machines), Ex Vivo Organ Perfusion, Technique (Normothermic, Hypothermic), Cell Perfusion, by Type (Microfluidic, Bioreactor)) - 2019 to 2024 1

Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Oxygenators, Heart-lung Machines), Ex Vivo Organ Perfusion, Technique (Normothermic, Hypothermic), Cell Perfusion, by Type (Microfluidic, Bioreactor)) - 2019 to 2024 2

Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Oxygenators, Heart-lung Machines), Ex Vivo Organ Perfusion, Technique (Normothermic, Hypothermic), Cell Perfusion, by Type (Microfluidic, Bioreactor)) - 2019 to 2024 3

Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Oxygenators, Heart-lung Machines), Ex Vivo Organ Perfusion, Technique (Normothermic, Hypothermic), Cell Perfusion, by Type (Microfluidic, Bioreactor)) - 2019 to 2024 4

Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Oxygenators, Heart-lung Machines), Ex Vivo Organ Perfusion, Technique (Normothermic, Hypothermic), Cell Perfusion, by Type (Microfluidic, Bioreactor)) - 2019 to 2024 5

Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Oxygenators, Heart-lung Machines), Ex Vivo Organ Perfusion, Technique (Normothermic, Hypothermic), Cell Perfusion, by Type (Microfluidic, Bioreactor)) - 2019 to 2024 6

Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Oxygenators, Heart-lung Machines), Ex Vivo Organ Perfusion, Technique (Normothermic, Hypothermic), Cell Perfusion, by Type (Microfluidic, Bioreactor)) - 2019 to 2024 7

Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Oxygenators, Heart-lung Machines), Ex Vivo Organ Perfusion, Technique (Normothermic, Hypothermic), Cell Perfusion, by Type (Microfluidic, Bioreactor)) - 2019 to 2024 8
Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Oxygenators, Heart-lung Machines), Ex Vivo Organ Perfusion, Technique (Normothermic, Hypothermic), Cell Perfusion, by Type (Microfluidic, Bioreactor)) - 2019 to 2024 7

1 Global Perfusion Systems Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Perfusion Systems Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Perfusion Systems Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Perfusion Systems Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Perfusion Systems Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Perfusion Systems Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Perfusion Systems Market – By Application (Market Size – & million/billion)
8.1 Cardiopulmonary Perfusion Systems
8.2 Cell Perfusion Systems
8.3 EX Vivo Organ Perfusion

9 Global Perfusion Systems Market – By Component
9.1 Oxygenators
9.2 Heart-Lung Machines
9.3 Perfusion Pumps
9.4 Cannulas
9.5 Monitoring Systems
9.6 Other

10 Global Perfusion Systems Market – By Type
10.1 Bioreactor Perfusion Systems
10.2 Microfluidic Perfusion Systems
10.3 Gravity Or Pressure-Driven Perfusion Systems
10.4 Small-Mammal Organ Perfusion Systems

11 Global Perfusion Systems Market – By Technique
11.1 Hypothermic Machine Perfusion Cardiac Centers
11.2 Normothermic Machine Perfusion

12 Global Perfusion Systems Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global Perfusion Systems Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global Perfusion Systems Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Getinge AB
14.3 Medtronic PLC
14.4 Livanova PLC
14.5 Terumo Corporation
14.6 Merck KGaA
14.7 Harvard Bioscience, Inc.
14.8 Nipro Corporation
14.9 Repligen Corporation
14.10 Spectrum Laboratories, Inc.
14.11 Xenios AG (Acquired By Fresenius Medical Care AG & Co. KGaA)
14.12 Company 11 & more

15 Global Perfusion Systems Market – Appendix
15.1 Sources
15.2 Abbreviations